lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
5,158 rows where filing_period = "fourth_quarter" and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3473694 | BALLARD PARTNERS a60550e1-ef89-4b45-ba66-49cd84724ec6 | 4T | BALLARD PARTNERS | 401104288 | EXTHERA MEDICAL CORPORATION | 2025 | fourth_quarter | MED | Guidance and advocacy related to procurement approval from the VA and DoD health systems. | Health & Human Services, Dept of (HHS) | 20000 | 0 | 1 | 2025-11-05T11:20:40-05:00 | |
| 3477073 | REPUBLIC CONSULTING, LLC dd0fed67-4de3-46db-b1c6-caf7dfa73d43 | Q4 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2025 | fourth_quarter | MED | Monitor health data budgets and policy. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-12-20T11:23:12-05:00 | |
| 3477097 | THE PETRIZZO GROUP, INC. 7fc31382-04f1-4000-a85e-21cd41e360e5 | 4T | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2025 | fourth_quarter | MED | Increased funding for pediatric medical research | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 1 | 2025-12-20T13:35:17-05:00 | |
| 3477532 | FRANCIS EDWARD & CRONIN, INC. c5be3f19-9a8e-48ae-a2de-a63a7ab3ccbd | Q4 | FRANCIS EDWARD & CRONIN, INC. | 311314 | LEWY BODY DEMENTIA ASSOCIATION | 2025 | fourth_quarter | MED | Legislation related to Alzheimer's disease and related dementias research. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2026-01-01T10:14:40-05:00 | |
| 3477779 | FRANCIS EDWARD & CRONIN, INC. b4d8c37b-642e-4fff-8d04-e96ba14a30ba | 4T | FRANCIS EDWARD & CRONIN, INC. | 311314 | LEWY BODY DEMENTIA ASSOCIATION | 2025 | fourth_quarter | MED | Legislation related to Alzheimer's disease and related dementias research. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 1 | 2026-01-02T14:48:48-05:00 | |
| 3477784 | THE HARRIS FIRM 8ff63cab-a488-4bf3-a0c7-94ea04e0da6f | Q4 | THE HARRIS FIRM | 68376 | HOLISTIC INDUSTRIES INC. | 2025 | fourth_quarter | MED | Issues pertaining to cannabis CSA scheduling. | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE | 80000 | 0 | 0 | 2026-01-02T15:00:59-05:00 | |
| 3477887 | RAY C CULVER III 60392821-1b84-4ffa-8e72-e5fe01f9aa82 | Q4 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2025 | fourth_quarter | MED | USDA ARS Human Nutrition Research funding in FY2025 Full-Year Continuing Appropriations and Extensions Act, P.L. 119-4, and FY2026 Agriculture Appropriations in P.L. 119-37. USDA ARS Human Nutrition Research funding authority in the reauthorization of the Agriculture Improvement Act of 2018, P.L. 115-334. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-03T22:14:28-05:00 | |
| 3478078 | DQB INTERNATIONAL cef2c716-a976-4ab7-8f82-9c0c62545f31 | Q4 | DQB INTERNATIONAL | 291834 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 2025 | fourth_quarter | MED | FY 2026 Labor, HHS, Appropriations Bill. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-01-05T11:39:44-05:00 | ||
| 3478081 | MCDERMOTT+ LLC 26d169cb-11a1-4501-a455-57fafddda1e8 | Q4 | MCDERMOTT+ LLC | 401103287 | VERILY LIFE SCIENCES LLC | 2025 | fourth_quarter | MED | Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-05T11:39:55-05:00 | |
| 3478127 | PARK GOVERNMENT RELATIONS, LLC f9a0c8d9-e8dd-4983-8064-583761f895d4 | Q4 | PARK GOVERNMENT RELATIONS, LLC | 401106398 | MEDICOM TECHNOLOGIES, INC | 2025 | fourth_quarter | MED | clinical image exchange, HTI-2 | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2026-01-05T12:55:04-05:00 | |
| 3478162 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 2283f356-b9e7-418a-a644-8b6c7ca1078e | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS SYSTEM | 2025 | fourth_quarter | MED | Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2026-01-05T13:21:15-05:00 | |
| 3478181 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 0827057e-ee14-443f-b4f5-8c57f9602a7f | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CHILDREN'S NATIONAL MEDICAL CENTER | 2025 | fourth_quarter | MED | Health-related issues including reimbursement, research, public-health & clinical care. | Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2026-01-05T13:29:03-05:00 | |
| 3478188 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 05d05cc6-bbb3-4283-b263-792d9c0c330a | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2025 | fourth_quarter | MED | Issues related to Medicare/Medicaid reimbursement and clinical research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-05T13:30:58-05:00 | |
| 3478209 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 12c72ea9-0918-4cc1-be5f-8581abeaceca | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | HAZELDEN BETTY FORD FOUNDATION | 2025 | fourth_quarter | MED | Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-05T13:50:50-05:00 | |
| 3478505 | AMERICAN COLLEGE OF CLINICAL PHARMACY fdc9720a-30cd-4f38-b544-e86228eaa7d1 | Q4 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2025 | fourth_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2026-01-06T10:19:08-05:00 | |
| 3478612 | AUBURN HEALTH STRATEGIES, LLC e5d11f1f-181d-4945-8baa-cf2e4da98372 | Q4 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2025 | fourth_quarter | MED | proficiency testing for clinical laboratories | Centers For Medicare and Medicaid Services (CMS),Office of Management & Budget (OMB) | 0 | 0 | 2026-01-06T11:23:47-05:00 | ||
| 3478678 | THE ROOSEVELT GROUP 00b4d395-0924-47e3-bf02-819a385937da | Q4 | THE ROOSEVELT GROUP | 400886595 | LSU HEALTH SCIENCES FOUNDATION | 2025 | fourth_quarter | MED | Provide advocacy and support of research and development efforts inside the DoD and NIH | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-06T12:06:54-05:00 | |
| 3478683 | THE ROOSEVELT GROUP eed1951f-e6dc-4b37-8f9c-22d9e0f2e004 | Q4 | THE ROOSEVELT GROUP | 400886595 | GUAM REGIONAL MEDICAL CITY | 2025 | fourth_quarter | MED | Lobbying on health issues specifically on Medicate in the US territories | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2026-01-06T12:07:54-05:00 | |
| 3478774 | THE ROOSEVELT GROUP cfa117eb-d0b5-4ad3-9bb2-90a9c9fa17fe | Q4 | THE ROOSEVELT GROUP | 400886595 | GUAM REGIONAL MEDICAL CITY | 2025 | fourth_quarter | MED | Lobbying on health issues specifically on Medicate in the US territories | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2026-01-06T14:00:59-05:00 | |
| 3478829 | MAGILL ASSOCIATES, LLC c0c76b42-bb38-478d-a6e4-79ee7b0b19b6 | Q4 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2025 | fourth_quarter | MED | FY 2026 appropriations for the development of a synthetic vaccine | HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-01-06T15:46:47-05:00 | ||
| 3479413 | CAPSTONE NATIONAL PARTNERS a6cd2641-143b-4a06-bb9d-26fe4979af3c | Q4 | CAPSTONE NATIONAL PARTNERS | 8214 | ATTERX BIOTHERAPEUTICS | 2025 | fourth_quarter | MED | FY26 Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2026-01-08T09:32:16-05:00 | |
| 3479494 | CORNERSTONE GOVERNMENT AFFAIRS, INC. a9af95b2-4ef3-4c40-9203-e03bdf1c060f | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MMV MEDICINES FOR MALARIA VENTURE | 2025 | fourth_quarter | MED | The purpose was to increase funding for malaria research in the Department of Defense. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-08T11:23:34-05:00 | |
| 3479768 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 3e492e93-1bde-4869-b61c-25fb874965ef | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS AT SAN ANTONIO | 2025 | fourth_quarter | MED | Identify federal funding opportunities and partnerships with federal agencies. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-08T14:26:57-05:00 | |
| 3480027 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 22708aca-e82a-4f53-a9d6-a2b8858673e2 | Q4 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2025 | fourth_quarter | MED | vaccines, ACIP, 340B, cdc reform, nih reform, pediatric research, NIH budget, FAIR Act, indirect costs, whole genome sequencing, high cost drugs, CMMI | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 30780 | 0 | 0 | 2026-01-09T08:46:09-05:00 | |
| 3480076 | ESHAM STRATEGIES LLC 9f9a60ae-46c7-4819-b8fd-efbaede1594f | Q4 | ESHAM STRATEGIES LLC | 401109169 | ACCUMULUS SYNERGY, INC. | 2025 | fourth_quarter | MED | Issues related to regulatory information exchange policies. | 20000 | 0 | 0 | 2026-01-09T10:38:43-05:00 | ||
| 3480177 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) f193a673-084e-4bf0-8b33-1c7de93ac281 | Q4 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2025 | fourth_quarter | MED | * On October 30, ADLM joined with other healthcare groups in writing to House and Senate leaders supporting H.R.5269/S.2761, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would create a new, more equitable Medicare clinical laboratory fee schedule. ADLM also conducted a grassroots campaign targeting House and Senate members in support of the legislation. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-09T13:21:23-05:00 | |
| 3480367 | NELSON MULLINS RILEY & SCARBOROUGH 0e0b9199-2214-4be0-bf98-f917b5d39156 | Q4 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | ANBEX, INC. | 2025 | fourth_quarter | MED | Stockpile potassium iodide to counteract effects of nuclear radiation. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2026-01-09T16:57:33-05:00 | |
| 3481040 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 5e376279-2ef4-479a-a9e3-ec78cc4ef088 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CASE WESTERN RESERVE UNIVERSITY | 2025 | fourth_quarter | MED | Issues related to the FAIR model, federal grants and general higher education issues. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2026-01-12T10:07:19-05:00 | |
| 3481095 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 113876c1-22d5-4531-9bef-5041b9dd6287 | Q4 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | 24486 | OSTEAL THERAPEUTICS, INC. | 2025 | fourth_quarter | MED | General federal government relations | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-12T10:29:25-05:00 | |
| 3481173 | CANNON|PEARCE FKA MR. MATT PEARCE ae460d7b-80aa-46ba-98d6-6ffd45ba446e | Q4 | CANNON|PEARCE FKA MR. MATT PEARCE | 401108148 | SIMVANA | 2025 | fourth_quarter | MED | Medical education and training | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2026-01-12T10:55:53-05:00 | |
| 3481196 | SQUIRE PATTON BOGGS e6c20b5e-5d91-47ad-8375-beb384c59925 | Q4 | SQUIRE PATTON BOGGS | 30906 | LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. | 2025 | fourth_quarter | MED | Funding support for federally qualified health centers; reauthorization of programs | 20000 | 0 | 0 | 2026-01-12T11:01:52-05:00 | ||
| 3481266 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 394f578c-5762-47db-a227-135034939cfd | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | ADVANCED MATERIALS AND DEVICES, INC. | 2025 | fourth_quarter | MED | Educated key government stakeholders on AMADs products applicable to the military and supported appropriations requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-12T12:09:15-05:00 | |
| 3481277 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 34eae797-f2ac-4181-9203-068c33190a63 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM | 2025 | fourth_quarter | MED | Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-01-12T12:12:54-05:00 | ||
| 3481281 | CORNERSTONE GOVERNMENT AFFAIRS, INC. eaa9f3df-99ca-432f-b6aa-fa65b9795665 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MEDIVIEW XR, INC. | 2025 | fourth_quarter | MED | Educated government stakeholders on Mediviews technology and capabilities in support of clinical training and graduate medical education. | Defense, Dept of (DOD) | 30000 | 0 | 0 | 2026-01-12T12:14:26-05:00 | |
| 3481294 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 13ffd3b9-4d7a-4ed7-94ee-2b83f72b4333 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | NIRSENSE, LLC (FKA BIONICA LABS) | 2025 | fourth_quarter | MED | Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-12T12:17:12-05:00 | |
| 3481339 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 97a75ed0-fcc6-4698-a784-f7918cd613b5 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | OCTAPHARMA USA, INC. | 2025 | fourth_quarter | MED | Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security. | Defense, Dept of (DOD),SENATE | 90000 | 0 | 0 | 2026-01-12T12:52:21-05:00 | |
| 3481353 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 72e08ee5-e880-4f32-9447-aee5351610e9 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | TELEFLEX INCORPORATED | 2025 | fourth_quarter | MED | Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. | Defense, Dept of (DOD) | 20000 | 0 | 0 | 2026-01-12T12:53:46-05:00 | |
| 3481358 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f21f146e-67a3-49a3-b01a-6ea65a0d8fd0 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE GENEVA FOUNDATION | 2025 | fourth_quarter | MED | Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-12T12:55:21-05:00 | |
| 3481361 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 36a394fd-19a1-4108-940b-e6cc730b3718 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ | 2025 | fourth_quarter | MED | Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-12T12:56:59-05:00 | |
| 3481373 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 729941e3-f1a4-4012-b56b-c16f932de9ec | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | WASHINGTON STATE UNIVERSITY | 2025 | fourth_quarter | MED | Educated key government stakeholders on WSUs research and development activities in support of US Service members; support Defense appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-12T13:01:29-05:00 | |
| 3481377 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 6d881c8f-29dd-4735-a051-0d907c69cfed | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | SMITH & NEPHEW | 2025 | fourth_quarter | MED | Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-12T13:04:32-05:00 | |
| 3481722 | LIVE OAK STRATEGIES efe0be58-ce6e-47c0-b6d7-0a201b72e3ec | Q4 | LIVE OAK STRATEGIES | 401105683 | KIMERA LABS | 2025 | fourth_quarter | MED | Issues related to lab safety. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2026-01-12T15:59:53-05:00 | |
| 3481779 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION dd62fbcf-9eb6-4dab-b682-bd5c21c639ca | Q4 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION | 319118 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION | 2025 | fourth_quarter | MED | indirect cost allocations for federal grants Medicaid | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-12T16:49:52-05:00 | |
| 3482213 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d575b157-5c08-4de7-9ccc-279d4a03d87a | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | DEFENSE HEALTH RESEARCH CONSORTIUM | 2025 | fourth_quarter | MED | HR 4016/S 2572, FY26 Defense Appropriations Act, Defense Health Research Programs; HR 3906, Medical Research For Our Troops Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-13T10:56:35-05:00 | |
| 3482222 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b00da1ee-1cdd-4224-8694-d595063b847d | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2025 | fourth_quarter | MED | HR 4016/S 2572, FY26 Defense Appropriations Act, Pancreatic Cancer Research Program; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on pancreatic cancer | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-13T10:59:15-05:00 | |
| 3482227 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d2bd5d4a-b2d1-4e14-aeda-0c377d94132a | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | FOUNDATION FOR PERIPHERAL NEUROPATHY | 2025 | fourth_quarter | MED | HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for peripheral neuropathy; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2026-01-13T11:00:03-05:00 | |
| 3482232 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a3c022ab-b797-46b0-9f83-dc92ce4cfeb4 | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2025 | fourth_quarter | MED | HR 4016/S 2572, FY26 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-13T11:01:28-05:00 | |
| 3482234 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b9a2be31-36d3-4429-9d81-36ae34b0a24c | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | VHL ALLIANCE | 2025 | fourth_quarter | MED | HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Prgoram designation for VHL; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on Von Hippel-Lindau syndrome | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-13T11:02:14-05:00 | |
| 3482449 | SQUIRE PATTON BOGGS b22fcc9c-c20f-4e27-b01d-2c5b9ca1f88b | Q4 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2025 | fourth_quarter | MED | Preparedness and response as it relates to Biosecurity. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-13T13:31:25-05:00 | |
| 3482455 | SQUIRE PATTON BOGGS 4b9ccf1c-f6b7-445f-98e0-97ff95ba9061 | Q4 | SQUIRE PATTON BOGGS | 30906 | ALPHYN BIOLOGICS | 2025 | fourth_quarter | MED | Advocacy work around Atopic Dermatitis (eczema). | Health & Human Services, Dept of (HHS),SENATE | 30000 | 0 | 0 | 2026-01-13T13:32:33-05:00 | |
| 3482647 | ACORN CONSULTING c44bdf7a-0e0c-4df0-8f5b-9aed8679468a | Q4 | ACORN CONSULTING | 401107972 | THORAGENIX INNOVATIONS, INC. | 2025 | fourth_quarter | MED | Advancing study and approval for medical devices | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-13T14:36:45-05:00 | |
| 3482691 | CURE SMA e073e824-3d5c-4e57-bbd9-598dc32bebb5 | Q4 | CURE SMA | 401104586 | CURE SMA | 2025 | fourth_quarter | MED | medical research in spinal muscular atrophy, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, U.S. Department of Defense Congressionally Directed Medical Research Program, Medical Research for Our Troops Act (H.R. 3906) | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 75000 | 0 | 0 | 2026-01-13T15:04:35-05:00 | |
| 3482797 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 74485d2d-a1c8-40ec-972c-bfb0e289330b | Q4 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 401103161 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 2025 | fourth_quarter | MED | NONE | 10000 | 0 | 0 | 2026-01-13T15:46:45-05:00 | ||
| 3483841 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) e0298c59-34c3-49e9-bd7d-e3a8e5c4ff19 | Q4 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | INTUITIVE SURGICAL, INC. | 2025 | fourth_quarter | MED | Lobbying related to health care issues. | 40000 | 0 | 0 | 2026-01-14T12:54:39-05:00 | ||
| 3483999 | IMPACT MANAGEMENT GROUP 86f8370b-86b4-4a6c-9b34-ab75043d18ab | Q4 | IMPACT MANAGEMENT GROUP | 401104137 | ARKANSAS RESEARCH ALLIANCE | 2025 | fourth_quarter | MED | On behalf of client support continued and future funding for clinical research programs in Arkansas | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-01-14T13:47:32-05:00 | ||
| 3484005 | BURRELL INTERNATIONAL GROUP LLC 102ae407-9f18-4b22-b52b-0329925c94fc | Q4 | BURRELL INTERNATIONAL GROUP LLC | 401103483 | BIOFACTURA, INC. | 2025 | fourth_quarter | MED | Medical Countermeasure Development for Smallpox and FY26 LHHS Appropriation | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-14T13:49:01-05:00 | |
| 3484099 | IMPACT MANAGEMENT GROUP d35675fc-ef1a-4308-8d9d-f498d24af450 | Q4 | IMPACT MANAGEMENT GROUP | 401104137 | CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. | 2025 | fourth_quarter | MED | On behalf of Client support continued and future funding for CARTI in Arkansas | HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-01-14T14:09:01-05:00 | ||
| 3484142 | BURRELL INTERNATIONAL GROUP LLC 96c3ef8a-5408-4f02-ad1d-c5ec35c8c13a | Q4 | BURRELL INTERNATIONAL GROUP LLC | 401103483 | OXYGENIUM INC. | 2025 | fourth_quarter | MED | Funding for portable oxygen generation systems; No specific legislation at this time. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-01-14T14:17:12-05:00 | ||
| 3484615 | CORNERSTONE GOVERNMENT AFFAIRS, INC. d4f820a5-f8b7-41f9-ac9b-7b6af06b16e7 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | AMERICAN SOCIETY FOR RADIATION ONCOLOGY | 2025 | fourth_quarter | MED | Discussions regarding patient access to radiation oncology. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES | 50000 | 0 | 0 | 2026-01-14T15:57:00-05:00 | |
| 3484859 | BALLARD PARTNERS 74284869-c4ac-4fd3-9697-d46afda4d82c | Q4 | BALLARD PARTNERS | 401104288 | INSIGHTEC, INC. | 2025 | fourth_quarter | MED | Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 90000 | 0 | 0 | 2026-01-14T18:35:23-05:00 | |
| 3484936 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 83cab83a-a495-4f27-a874-e28b31b09d0c | Q4 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES | 18411 | F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 2025 | fourth_quarter | MED | (MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2026-01-14T20:46:17-05:00 | |
| 3484964 | BALLARD PARTNERS 4c8c549f-b542-4ca5-a0fa-af6b31bd420e | Q4 | BALLARD PARTNERS | 401104288 | LIFESCIENCE LOGISTICS | 2025 | fourth_quarter | MED | Government stockpile storage. | Health & Human Services, Dept of (HHS) | 80000 | 0 | 0 | 2026-01-14T21:30:51-05:00 | |
| 3485048 | HOLLAND & KNIGHT LLP 97a8f555-2a1d-4843-b04b-c79522bd3eba | Q4 | HOLLAND & KNIGHT LLP | 18466 | RIVERIA INVESTMENT GROUP ON BEHALF OF ON THE RIGHT TRACK | 2025 | fourth_quarter | MED | Support efforts to reduce healthcare acquired infections (HAIs) and improve infection prevention effort. | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2026-01-15T06:57:06-05:00 | |
| 3485067 | ZIMMER BIOMET, INC. 18f0c85b-d7db-4819-bd61-b1cf15dc0056 | Q4 | ZIMMER BIOMET, INC. | 292755 | ZIMMER BIOMET, INC. | 2025 | fourth_quarter | MED | Breakthrough devices; | HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2026-01-15T07:59:43-05:00 | |
| 3485183 | MANATT, PHELPS, AND PHILLIPS da53747d-7ca7-45b6-806f-322152146718 | Q4 | MANATT, PHELPS, AND PHILLIPS | 23645 | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2025 | fourth_quarter | MED | Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2026-01-15T09:22:19-05:00 | |
| 3485217 | MANATT, PHELPS, AND PHILLIPS b3f0ed0e-72e5-48e9-b91a-bd6c29b7bebd | Q4 | MANATT, PHELPS, AND PHILLIPS | 23645 | MEDISYS HEALTH NETWORK | 2025 | fourth_quarter | MED | Provider Relief and COVID funding and other healthcare issues; Community Project Funding | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-15T09:28:36-05:00 | |
| 3485634 | BALLARD PARTNERS 7b92fc22-4bcd-4a6c-ba33-93d402d64bb3 | Q4 | BALLARD PARTNERS | 401104288 | NOVAVAX, INC. | 2025 | fourth_quarter | MED | Guidance navigating vaccine policy. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2026-01-15T11:09:49-05:00 | |
| 3485903 | AMERICAN PHYSICAL THERAPY ASSOCIATION 2ef6b124-c8b5-4a92-b685-0a334ed4d7fc | Q4 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2025 | fourth_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 301389 | 0 | 0 | 2026-01-15T12:02:06-05:00 | |
| 3486282 | S-3 GROUP 8e71e793-925a-4027-b303-add42e8087b8 | Q4 | S-3 GROUP | 400774330 | ORCHARD THERAPEUTICS NORTH AMERICA | 2025 | fourth_quarter | MED | Issues related to funding for newborn screenings for metachromatic leukodystrophy | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2026-01-15T13:34:45-05:00 | |
| 3486407 | S-3 GROUP b8996289-da07-423a-b5b5-3ae0bb424b94 | Q4 | S-3 GROUP | 400774330 | BAXTER HEALTHCARE CORPORATION | 2025 | fourth_quarter | MED | Promote kidney care and positive patient outcomes | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2026-01-15T13:50:53-05:00 | |
| 3486413 | TROUTMAN STATEGIES 06f0a4b5-8e12-41e3-8838-edaf1734c458 | Q4 | TROUTMAN STATEGIES | 81511 | MURAL HEALTH | 2025 | fourth_quarter | MED | Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-15T13:52:38-05:00 | |
| 3486598 | AVIVA STRATEGIES (FKA MGB CONSULTING) c6a8cfd2-f6d4-4673-ae10-262f3ba5b10a | Q4 | AVIVA STRATEGIES (FKA MGB CONSULTING) | 401109532 | ELEMENT BIOSCIENCES | 2025 | fourth_quarter | MED | - National Security Commission on Emerging Biotechnology | HOUSE OF REPRESENTATIVES,SENATE | 39000 | 0 | 0 | 2026-01-15T14:24:47-05:00 | |
| 3486975 | THE FERGUSON GROUP f88c975a-b3fb-4d8f-8476-c5cce60938c7 | Q4 | THE FERGUSON GROUP | 14451 | WAKE COUNTY NC | 2025 | fourth_quarter | MED | Communicate Wake EMSs support for S. 2586, Drug Shortages Prevention and Quality Improvement Act and H.R.2416, To amend the Public HealthService Act to reauthorize a military and civilian partnership for trauma readiness grant program. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-15T15:25:17-05:00 | |
| 3487102 | THE LIVINGSTON GROUP, LLC 3730a1e5-cad9-4d97-a589-d5c0d724e4bc | Q4 | THE LIVINGSTON GROUP, LLC | 49635 | INNOVATIVE VACCINE TECHNOLOGIES | 2025 | fourth_quarter | MED | FY2026 appropriations for the development of a synthetic vaccine | 0 | 0 | 2026-01-15T15:51:30-05:00 | |||
| 3487648 | BALLARD PARTNERS 80bcc72b-aa74-425d-9049-33a24e651873 | Q4 | BALLARD PARTNERS | 401104288 | REVELLE AESTHETICS, INC. | 2025 | fourth_quarter | MED | Promoting the advancement of healthcare technology. | Health & Human Services, Dept of (HHS) | 300000 | 0 | 0 | 2026-01-15T20:09:57-05:00 | |
| 3487790 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 4a5e87a8-9842-4e72-a28f-3f51c6dea851 | Q4 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. | 401104196 | OAK RIDGE ASSOCIATED UNIVERSITIES, INC. | 2025 | fourth_quarter | MED | FY2025; Labor H Appropriations; including emergency preparedness issues and health programs | Health & Human Services, Dept of (HHS) | 30000 | 0 | 0 | 2026-01-16T08:36:01-05:00 | |
| 3487834 | IPOLICY SOLUTIONS ed9497b8-cb57-4417-a784-9ff65a499f21 | Q4 | IPOLICY SOLUTIONS | 401105127 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2025 | fourth_quarter | MED | No bill #: legislation to clarify CLIA | HOUSE OF REPRESENTATIVES,SENATE | 70500 | 0 | 0 | 2026-01-16T09:09:09-05:00 | |
| 3488370 | AMERICAN CLINICAL LABORATORY ASSN c06b5cea-3cd3-4f14-aadf-cbb5a0aec4c4 | Q4 | AMERICAN CLINICAL LABORATORY ASSN | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 2025 | fourth_quarter | MED | Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform. | HOUSE OF REPRESENTATIVES,SENATE | 930000 | 0 | 0 | 2026-01-16T11:06:05-05:00 | |
| 3488447 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 03b5f517-3e5d-4643-835e-fc03102208e7 | Q4 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | GINKGO BIOWORKS, INC. | 2025 | fourth_quarter | MED | Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2026-01-16T11:22:44-05:00 | |
| 3488474 | ISEMAN & ASSOCIATES LLC ee4b8466-942a-40ed-81c2-63bef659143b | Q4 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2025 | fourth_quarter | MED | Monitoring biotech legislation | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-01-16T11:25:32-05:00 | ||
| 3488501 | NESTPOINT ASSOCIATES LLC 58c0b27b-5c00-4896-97c5-7e841e37e05a | Q4 | NESTPOINT ASSOCIATES LLC | 401109225 | URGENTFLEX HOLDING LLC | 2025 | fourth_quarter | MED | Awareness of hyperbaric medical therapies. | Health & Human Services, Dept of (HHS) | 40000 | 0 | 0 | 2026-01-16T11:28:32-05:00 | |
| 3489302 | TEAM HALLAHAN LLC 96b97073-7aa0-4602-9080-796ef0f655e0 | Q4 | TEAM HALLAHAN LLC | 401104228 | THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION) | 2025 | fourth_quarter | MED | Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-01-16T13:13:43-05:00 | ||
| 3489474 | STANFORD UNIVERSITY 77603d10-703a-49a3-ba64-d4312507cc0a | Q4 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2025 | fourth_quarter | MED | Policies with regard to indirect cost reimbursement rates at NIH | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2026-01-16T13:42:02-05:00 | |
| 3489559 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 5978d2c8-b2b6-4ce9-94f3-15e5ce8a05ca | Q4 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. | 52925 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. | 2025 | fourth_quarter | MED | HR 2319/S 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2026-01-16T13:53:55-05:00 | |
| 3489565 | THE CORMAC GROUP, LLC 2202b2f3-f48b-4320-b876-36eec1e4d0d2 | Q4 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2025 | fourth_quarter | MED | appropriations, DOD, TBI research, veterans issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2026-01-16T13:55:12-05:00 | |
| 3489619 | AMERICAN ASSOCIATION FOR CANCER RESEARCH 44a0c2cf-e748-4227-b6cd-dca52bca6480 | Q4 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 400601833 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 2025 | fourth_quarter | MED | Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2026-01-16T14:08:45-05:00 | |
| 3489802 | UNIVERSITY OF KENTUCKY e7644fb9-985b-4421-ad3b-f7accc62d6e7 | Q4 | UNIVERSITY OF KENTUCKY | 400287372 | UNIVERSITY OF KENTUCKY | 2025 | fourth_quarter | MED | NIH Funding FY26 | HOUSE OF REPRESENTATIVES,SENATE | 85000 | 0 | 0 | 2026-01-16T14:34:24-05:00 | |
| 3489909 | THE JACKSON LABORATORY a53496ec-3669-4a1f-9088-03a20ae38b4b | Q4 | THE JACKSON LABORATORY | 401104723 | THE JACKSON LABORATORY | 2025 | fourth_quarter | MED | Issues related to biomedical research. Animal model use in biomedical research. Issues related to indirect costs/facilities and administration reimbursement. | HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE | 30000 | 0 | 0 | 2026-01-16T14:49:21-05:00 | |
| 3490081 | BOLD STRATEGIES, LLC fce8f8ed-d7ac-42a9-b1b0-be5a031ffec5 | Q4 | BOLD STRATEGIES, LLC | 401104653 | PENNINGTON BIOMEDICAL RESEARCH CENTER | 2025 | fourth_quarter | MED | Nutrition and obesity research. Appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-16T15:07:00-05:00 | |
| 3490094 | AMERICAN SOCIETY OF HEMATOLOGY acf2e93b-a909-451a-b8ca-65a1059e7ac5 | Q4 | AMERICAN SOCIETY OF HEMATOLOGY | 59171 | AMERICAN SOCIETY OF HEMATOLOGY | 2025 | fourth_quarter | MED | Sickle cell disease/trait issues Hematology/oncology treatment issues Hematology/oncology drug research and approval issues General hematology public health and research issues Open access policy for peer reviewed research journals Women's health and research Issues impacting blood supply shortages/safety Issues impacting delivery of bone marrow, peripheral blood, and cord blood Clinical trials regulations and coverage Issues impacting laboratory testing and pediatric reference intervals (PRIs) Issues impacting laboratory developed tests (LDTs) Issues impacting drug shortages FDA guidance impacting hematology Impact of restructuring and reorganization of federal public health and research agencies Issues related to vaccines and immunization practices for individuals with hematologic disorders | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),President of the U.S.,SENATE,White House Office | 30000 | 0 | 0 | 2026-01-16T15:08:12-05:00 | |
| 3490114 | DLA PIPER LLP (US) 3e3115b4-c01e-4af1-be13-e99d752844b8 | Q4 | DLA PIPER LLP (US) | 76855 | AVALYN PHARMA INC. | 2025 | fourth_quarter | MED | Issues related to lung disease and rare disease. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-16T15:09:39-05:00 | |
| 3490129 | DLA PIPER LLP (US) 2d72653d-4d3e-4a2d-86bc-146f91d8c1e6 | Q4 | DLA PIPER LLP (US) | 76855 | REGENXBIO INC. | 2025 | fourth_quarter | MED | Issues related to rare disease. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2026-01-16T15:11:24-05:00 | |
| 3490141 | DLA PIPER LLP (US) b8fdb26e-8ef1-42fd-a0dd-5936b299833c | Q4 | DLA PIPER LLP (US) | 76855 | PONYA DIAGNOSTICS, LLC | 2025 | fourth_quarter | MED | Issues related to CMS reimbursement. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2026-01-16T15:12:24-05:00 | |
| 3490149 | DLA PIPER LLP (US) 8f3a5f6e-7854-4522-968c-2e8a571aefd1 | Q4 | DLA PIPER LLP (US) | 76855 | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2025 | fourth_quarter | MED | Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2026-01-16T15:13:09-05:00 | |
| 3490571 | SKINCURE ONCOLOGY 53a96fc9-e942-430e-93ec-2116210bcf5a | Q4 | SKINCURE ONCOLOGY | 401109136 | SKINCURE ONCOLOGY | 2025 | fourth_quarter | MED | Education and provision of information regarding Image Guided Superficial Radiation therapy (IGSRT) while working on a coverage policy with CMS for IGSRT. | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2026-01-16T16:11:52-05:00 | |
| 3490754 | UNIVERSITY OF ROCHESTER fae62f12-a112-4470-92e6-0aac4030525e | Q4 | UNIVERSITY OF ROCHESTER | 301937 | UNIVERSITY OF ROCHESTER | 2025 | fourth_quarter | MED | National Institutes of Health, cancer/NCI, ARPA-H | HOUSE OF REPRESENTATIVES,SENATE | 108561 | 0 | 0 | 2026-01-16T16:42:48-05:00 | |
| 3491591 | ALPINE GROUP PARTNERS, LLC. f6d80dee-65c4-4235-8905-32eb4602e373 | Q4 | ALPINE GROUP PARTNERS, LLC. | 1171 | MENTAL HEALTH AMERICA | 2025 | fourth_quarter | MED | S. 3059/H.R.7708 REAL Health Providers Act Community Mental Health Services Block Grant Issues related to mental health in budget reconciliation Issues related to 988 Issues related to youth peer support services H.R. 1735/S. 779 EARLY Minds Act H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2026-01-17T11:53:43-05:00 | |
| 3491845 | TIBER CREEK GROUP cf034883-9666-4315-b134-ea79810fbcef | Q4 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2025 | fourth_quarter | MED | Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-17T14:01:32-05:00 | |
| 3492018 | AMERICAN SOCIETY OF ADDICTION MEDICINE dbc99f25-c3f7-4395-ba27-72f5713dfa35 | Q4 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2025 | fourth_quarter | MED | Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 70000 | 0 | 0 | 2026-01-17T15:49:45-05:00 | |
| 3492398 | FORBES-TATE 04eaab3c-5517-47b7-ad38-e2420b723166 | 4T | FORBES-TATE | 400976792 | SUPPLY LINE INTERNATIONAL MEDICAL, LLC | 2025 | fourth_quarter | MED | Issues related to drug shortages, specifically, IV fluids. | Food & Drug Administration (FDA) | 0 | 1 | 2026-01-17T20:00:58-05:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);